Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating Botulinum Toxins for Chronic Neck and Back Pain
NCT02008136Phase 1Unknown
- Sponsor
- United States Department of Veterans Affairs
- Start
- Mar 2016
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Onabotulinumtoxina + hydrogel in cervicalgia and low back pain (LBP), sponsored by United States Department of Veterans Affairs. Primary endpoint: Lumbar Pain Rating Scale at 3 months. Status: unknown.
02
Drugs
Onabotulinumtoxina + hydrogel
03
Conditions
cervicalgialow back pain (LBP)
Beyond the preview
Go deeper on NCT02008136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008136.